Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Slow FDA decision affects Gender Selection in the U.S.As FDA's approval of MicrosortTM remains pending, couples looking to select the gender of their children are stuck with only one reliable option: IVF combined with preimplantation genetic screening (PGS).
By: Center for Human Reproduction CHR’s Ethics Committee, in contrast, concluded that it was never ethical to withhold a more accurate methodology from the public (IVF+PGS is significantly more accurate in selecting gender than semen sorting), and felt strongly that patient rights to self-determination outweighed concerns raised by ASRM’s Ethics Committee. CHR communicated this difference in opinion in an exchange of correspondence with the ASRM and later in a publication in Fertility & Sterility, the official publication of the ASRM (Gleicher N, Karande V. Gender selection for nonmedical indications. Fertil Steril 2002;78:460- Since then, semen sorting, utilizing a patented methodology called Microsort™, and in selected circumstances IVF + PGS, have co-existed in the U.S. in clinical practice. To become the first sperm sorting technique with Food and Drug Administration (FDA) approval, the inventors of Microsort™ conducted a clinical trial in cooperation with a number of infertility centers to establish safety and efficacy of the methodology. Some centers, including CHR, offered IVF+PGD in parallel, mostly for family balancing purposes and (in compliance with ASRM guidelines) when other indications for IVF co-existed. The Microsort™ trial was completed over a year ago but a FDA decision has still not been reached/published. Until such a decision (it is presently unknown when that will be), patients in the U.S. have no effective sperm sorting methodology available for pre-fertilization gender selection. Other sperm sorting methodologies offered “on the street” or via the Internet have never been proven effective in changing the ratio of X and Y spermatozoa. This means that, at present, the only effective gender selection methodology available in the U.S. is IVF+PGS, also the most accurate method, with approximately 99% accuracy. CHR is among only a small number of fertility centers offering to qualified couples gender selection by IVF + PGD. Amongst those centers, only very few offer PGS in-house, as CHR does. Almost all centers send cells, taken off embryos, for analyses to specialty laboratories. By performing this laboratory analysis in-house, CHR avoids the need for overnight transportation of these valuable biological products. # # # About Center For Human Reproduction CHR (www.centerforhumanreprod.com) End
Account Email Address Disclaimer Report Abuse
|
|